Burden clinico ed economico delle infezioni del tratto urinario nei pazienti con lesioni midollari e sclerosi multipla in Italia [0.03%]
意大利多发性硬化和脊髓损伤患者泌尿系统感染的临床和经济负担
Gruppo GSC*
Gruppo GSC*
Introduction:: Urinary tract infections (UTIs) are common complications in patients with spinal cord injuries (SCI) and multiple sclerosis (MS), especially those using intermittent catheterization (IC) for neurogenic blad...
Dal quadro normativo alla pratica: il regolamento UE HTA 2021/2282, il ruolo dell'AIFA e le interazioni con gli sviluppatori: processi, interfacce, aspettative [0.03%]
从法规到实践：2021/2282号欧盟HTA条例、AIFA的角色以及与开发人员的互动：流程、接口和预期
Patrizia Popoli,Walter Marrocco,Anna Ponzianelli et al.
Patrizia Popoli et al.
Patient and public involvement in health technology assessment committees: who is free from conflicts of interest? [0.03%]
卫生技术评估委员会中的患者和公共参与：谁能免受利益冲突的影响？
Gustavo H Marin,Santiago Hasdeu
Gustavo H Marin
Scientific and technological advances have increased the capacity to prevent diseases, perform diagnoses, and develop innovative treatments. To analyze whether these technologies should be incorporated into healthcare systems, Health Techno...
Stima dei pazienti potenzialmente eleggibili alla terapia con icosapent etile in Italia mediante revisione dei dati di letteratura [0.03%]
通过文献资料审查估算意大利潜在符合条件的依思佳疗法患者的数目
Pasquale Perrone Filardi,Emanuela Arcangeli,Pierluigi Carullo et al.
Pasquale Perrone Filardi et al.
Introduction:: The literature and international Guidelines agree in identifying LDL cholesterol (LDL-C) control as the primary goal for reducing cardiovascular (CV) risk, while hypertriglyceridemia management is a seconda...
Optimising pediatric paracetamol and ibuprofen use: a retrospective study with expert evaluation of efficacy, safety, and healthcare costs [0.03%]
一项关于儿科帕拉西特胺和布洛芬使用的优化研究：疗效、安全性和医疗保健成本的专家评估（回顾性研究）
Andrea Marcellusi,Angela Ragonese,Antonio D&#x;Avino et al.
Andrea Marcellusi et al.
Background: Paracetamol and ibuprofen are widely used for fever and pain in children, but real-world prescribing often deviates from guidelines, leading to potentially avoidable complications and healthcare costs. ...
Conseguenze economiche dell’introduzione del dispositivo JADA® come trattamento alternativo per la gestione dell’emorragia postpartum in Italia [0.03%]
JADA®装置作为意大利产后出血管理替代疗法的引入对经济的影响分析
Andrea Marcellusi,Giulio Guarnotta,Carlo Tomino
Andrea Marcellusi
Introduction:: Postpartum Haemorrhage (PPH) represents one of the leading causes of maternal mortality globally. In addition to standard guidelines treatments of PPH, the JADA® device has proven to be clinically and econ...
The economic impact of multimorbidity in Italy: evaluation of direct costs and scenario analysis of patients with type 2 diabetes, heart failure, and chronic kidney disease using real-world data [0.03%]
意大利多病共存的经济影响：利用真实世界数据评估直接成本及2型糖尿病、心力衰竭和慢性肾脏疾病患者的场景分析
Valentina Perrone,Claudio Ripellino,Maria Cappuccilli et al.
Valentina Perrone et al.
Objectives: This study aimed to evaluate the healthcare costs associated with managing type 2 diabetes (T2D), chronic kidney disease (CKD), and heart failure (HF) in Italy. Specifically, the research investigated the econ...
RWE in oncologia: uso dei database per identificare i sottotipi molecolari del cancro mammario metastatico in Italia [0.03%]
RWE在肿瘤学中的应用：利用数据库识别意大利转移性乳腺癌的分子亚型
Valentina Perrone,Maria Cappuccilli,Melania Leogrande et al.
Valentina Perrone et al.
Hans Severens,Andrew Dillon,Francois Meyer et al.
Hans Severens et al.
The article explores the challenges and opportunities presented by the implementation of the EU Health Technology Assessment Regulation (EU HTAR). It highlights the varying degrees of readiness among Member States (MSs) and the perceived co...